Hester Biosciences Limited (HESTERBIO.BO)
Hester Biosciences Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Ahmedabad, GU, IN. The stock last traded at $2413.65, down 1.85% on the session, giving a market capitalisation of $20.50B. Its beta of 0.49 implies it has historically moved less than the broad market.
Hester Biosciences Limited, established in 1987 with its headquarters in Ahmedabad, India, operates as a key manufacturer and international distributor of veterinary vaccines and animal wellness products. The company organizes its extensive portfolio into specialized divisions, including Poultry Healthcare, Animal Healthcare, and Petcare. For poultry, it offers a comprehensive array of vaccines addressing various ailments such as Newcastle disease, infectious bronchitis, fowl pox, egg drop syndrome, and Marek's disease. Its livestock vaccine selection covers crucial conditions like goat pox, peste des petits ruminants, brucellosis, and lumpy skin disease. Beyond immunization, Hester Biosciences supplies a wide range of animal health solutions, comprising biosecurity and therapeutic formulas, herbal and homeopathic remedies, and nutritional feed supplements. The pet care segment provides products for digestive health, pain relief (NSAIDs), joint support, parasite elimination, coat nourishment, grooming, and anti-infective treatments. Additionally, the company produces diagnostic kits utilizing enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR) technologies.
Hester Biosciences Limited is most often compared with the following Healthcare names: